Pfizer says additional analysis shows its vaccine is 95% effective in preventing COVID-19, seeking FDA authorization

This picture taken on May 23, 2020 shows a laboratory technician holding a dose of a COVID-19 novel coronavirus vaccine candidate ready for trial on monkeys at the National Primate Research Center of Thailand at Chulalongkorn University in Saraburi. (Photo by MLADEN ANTONOV/AFP via Getty Images)

OAN Newsroom
UPDATED 7:05 PM PT – Wednesday, November 18, 2020

Pfizer officials have stated additional analysis from its experimental coronavirus vaccine suggested it’s more than 95 percent effective in preventing COVID-19.

On Wednesday, Pfizer and BioNTech released the updated data after initially estimating last week their vaccine was more than 90 percent effective.

The drugmakers stated its effectiveness was consistent across all ages, races and ethnicities with no serious side effects. Additionally, BioNTech’s CEO plans to submit an emergency use authorization to the FDA within days.

MORE NEWS: ICE Arrests 180 Immigrants In ‘Operation Broken Promise’

Source link

Author: Kayleighoann

Be the first to comment

Leave a Reply

Your email address will not be published.